Week In Review: Shanghai Pharma Bids In Cardinal China's $1.5 Billion Auction
October 14, 2017 at 18:29 PM EDT
Shanghai Pharma (SHA: 601607) and FountainVest Partners, a China private equity fund, have submitted second-round bids for Cardinal China's (NYSE: CAH) drug distribution operations.
